TGFB1 and cancer: Consequently, miR-148a suppresses the activation of TGF-β/SMAD2 signaling pathway, and attenuates cancer stem-cell-like functions in hepatocellular carcinoma and breast cancer cells in vitro and in vivo experiments [167,230].